IgA1分子异常糖基化在IgA肾病中致病机理的研究
被引量：1
摘要
IgA肾病中IgA1分子铰链区O 连接糖基半乳糖基化的水平降低 ,该糖基化异常可通过多种途径引起IgA1分子在肾小球的沉积和肾小球的炎性损伤。B细胞内β1、3半乳糖基转移酶活性的缺乏可能是IgA1分子异常糖基化的原因。对该糖基化异常的深入研究将有利于进一步阐明IgA肾病的发病机制并有望对IgA肾病的治疗提供新的思路。
出处
《国外医学（泌尿系统分册）》
2004年第2期281-284,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献23
-
1Matousovic K, Konecny K, Mestecky J, et al. IgA nephropathy . Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation. Cas Lek Cesk,2002,141(23) ,729 - 34.
-
2Feehally J. IgA nephropathy-a disorder of IgA production? Q J Med,1997,90,387 - 390.
-
3Qdum J,Peh CA, Oarksan AB, et al. Recurrent mesangial IgA nephritis following renal transplantation . Nephrol Dial Transplant, 1994,9,309- 12.
-
4Peppard JV. Russell MW: Phylogenetic development and comparative physiology of IgA. In Mucosal Immunology,PL Ogra, J Mestecky, MELamm, WStrber,JBienenstock, J RMcGhee(eds). SanDiego,Academic Press, 1999,pp163,180.
-
5Allen AC,Topham PS, Harper SJ,et al.Leucocyte β1,3 galactosyl transferase activity in IgA Nephropathy. Nephrol Dial Transplant, 1997,12,701- 106.
-
6Alessandro Amore , Paola Cirina, et al. Reactivity of mesangial cells with aberrantly glycosylated IgA: modulation by angiotensin-converting enzyme inhibitors. Nehrology, 2002,7,122 - 125.
-
7Davin JC, ten Berge IJ, et al. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int,2001,59,823 -34.
-
8Alice C, Elaine M, Patti EC. et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int,2001,60,969 - 973.
-
9Jiri Mestecky,Jan Novak,et al. Pathogenic potential of salactose-deficient IgA1 in IgA nephropathy. Nephrology,2002,7,92 - 99.
-
10Kokubo T, Hiki Y, Iwase H, et al. Evidence for involvement of IgA1 glycopeptide in the IgA1-IgA1 interaction in IgA nepphropathy . J Am Soc Nephrol, 1997,8,915 -919.
-
1李振,徐元宏.糖基化异常的IgA1分子与IgA肾病[J].国际检验医学杂志,2014,35(23):3236-3238. 被引量：5
-
2林淑芃.IgA肾病患者IgA1糖基化异常及其致病机制[J].中华肾病研究电子杂志,2015,4(6):40-44. 被引量：2
-
3王金泉.糖基化异常IgA1分子在IgA肾病致病机制中的作用[J].医学研究生学报,2011,24(10):9-12. 被引量：2
-
4涂金花,余英豪.IgA肾病异常糖基化IgA1分子的研究现状[J].医学综述,2010,16(24):3719-3722. 被引量：7
-
5孙玥,朱斌,朱彩凤.IgA1在过敏性紫癜性肾炎发病机制中的研究进展[J].深圳中西医结合杂志,2012,22(2):114-116. 被引量：1
-
6谢林伸,王立,黄俊,樊均明.IgA肾病中IgA1异常糖基化的致病机制[J].生物医学工程学杂志,2010,27(1):227-230. 被引量：5
-
7茹颖(综述),宋红梅(审校).IgA肾病发病机制的研究进展[J].国际儿科学杂志,2011,38(5):506-508.
-
8贺红光,曾彩虹.异常糖基化IgA1分子与IgA肾病[J].肾脏病与透析肾移植杂志,2009,18(4):370-374. 被引量：1
-
9陈蓉,程骏章.IgA肾病发病机制的研究进展[J].新医学,2012,43(11):816-819. 被引量：4
-
10白雅雯（综述）,饶向荣（审校）.低糖基化IgA1在IgA肾病中的作用[J].临床肾脏病杂志,2011,11(7):334-336. 被引量：1
